COMMUNIQUÉS West-GlobeNewswire

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors
23/01/2024
CELEBRATION, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the appointment of Alvin Shih, MD, MBA, to the [...]
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
23/01/2024
Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services LEXINGTON, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an [...]
Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application
23/01/2024
FDA continues to review the file past the Prescription Drug User Fee Act goal date of January 22, 2024 MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH [...]
Theratechnologies reçoit une mise à jour de la FDA concernant son supplément à la licence de produit biologique pour la formulation F8 de la tésamoréline
23/01/2024
La FDA continue d'examiner le dossier après la date butoir du Prescription Drug User Fee Act fixée au 22 janvier 2024 MONTRÉAL, 23 janv. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « [...]
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
23/01/2024
The presentation will review study population data from ONL’s Phase 2 study of ONL1204 Ophthalmic Solution in patients with Macula-Off Rhegmatogenous Retinal Detachment ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE [...]
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing
23/01/2024
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and innovation-led cell and [...]
First Wave BioPharma to Present at the DealFlow MicroCap Conference
23/01/2024
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]
Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
23/01/2024
NEW YORK, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, [...]
Grow Up Conference & Expo Announces Top 50 Cannabis Leaders in Canada Ahead of CannaVision '24 Executive Summit
23/01/2024
Leading cannabis event company celebrates national leaders and launches an exclusive gathering for decision-makers in the global arena Toronto, ON, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Grow Up Conference & Expo (“Grow [...]
A Cut Above: RIFF Cannabis Brand Expands Its Diamond Collection With New THCA ‘Liquid Diamond’ Vapes
23/01/2024
New RIFF Cannabis Collection Includes Diamond-Infused Multi-Packs of Pre-Rolls and Blunts TORONTO, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading [...]
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
23/01/2024
BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pentoxifylline Extended-Release (ER) Tablets, USP 400mg. ANI’s [...]
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
23/01/2024
Collaboration to accelerate research to determine role of GBA gene CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
23/01/2024
Company Announcement Net sales of DARZALEX ® in 2023 totaled USD 9,744 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; January 23, 2024 – Genmab A/S ( [...]
CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors
23/01/2024
First-of-its-kind, antibody-based, bivalent and bispecific MAGE-A4 T-cell engager ZURICH, Switzerland, Jan. 23, 2024 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced the clearance of an Investigational New Drug (IND) [...]
HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq
23/01/2024
HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq 1st institutional round for HEPHAISTOS-Pharma, getting on track to bring its lead product ONCO-Boost [...]
HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq
23/01/2024
HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ventures, la Fondation Fournier-Majoie et Noshaq 1er tour institutionnel pour HEPHAISTOS, en bonne voie pour amener son produit phare ONCO- [...]
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN
23/01/2024
Avextra, the German pharmaceutical company focused on Cannabis-Based Medicines (CBM) and the German Pain Association (DGS), the leading physicians’ society dedicated to chronic pain therapy, jointly announces their [...]
Ex dividend NOK 0.75 today
23/01/2024
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.
Change in Orion Group Executive Management Board – René Lindell appointed Chief Financial Officer of Orion
23/01/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS 23 JANUARY 2024 at 9.00 EET Change in Orion Group Executive Management Board – René Lindell appointed Chief Financial Officer of Orion [...]

Pages